MiniMed Group Financial Ratios
NASDAQ: MMEDHealth CareMedical/Dental InstrumentsUSD
19.71-0.09 (-0.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MiniMed Group ratio analysis
MiniMed Group earned a net margin of -10.7% in FY 2026, down from -7.8% a year earlier. Gross margin was 54.2% compared with a median of 57.2% over the prior 2 years. Return on equity reached -9.2%, meaning MiniMed Group generated -0.09 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
MiniMed Group financial ratios (annual)
| Ratio | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Price / sales | 1.09 | — | — |
| Price / book | 0.94 | — | — |
| Gross margin | 54.2% | 56.3% | 58.2% |
| Operating margin | -6.1% | -5.4% | -2.8% |
| Net margin | -10.7% | -7.8% | -4.5% |
| Free cash flow margin | -13.5% | -2.0% | -4.3% |
| Return on equity (ROE) | -9.2% | -6.4% | -3.2% |
| Return on assets (ROA) | -7.2% | -5.1% | — |
| Current ratio | 1.92 | 1.32 | — |
| Revenue growth | 14.3% | 10.0% | — |